Point-of-Care & Clinical Support

Dyania Health's AI-powered software automates patient identification from EHRs for clinical trial recruitment, serving hospitals, health systems, and pharmaceutical companies.

DynaMed Decisions is a groundbreaking clinical decision support solution designed to enhance clinical decision-making, decrease the burden on providers, and drive meaningful patient engagement. The solution includes tools that provide individualized clinical guidance based on the specifics of the patient being seen, as well as Option Grid patient decision aids for preference-sensitive decisions.

The EasyCell® assistant is a hematology imaging system by Medica Corporation that automates white cell differentials using AI-powered image processing and pattern recognition, significantly reducing review times and improving accuracy for laboratory technologists.

DynaMedex with Dyna AI provides comprehensive clinical decision support for physicians, integrating drug resources, chemo regimens, patient information, and evidence-based medicine.

AgileMD eCART is an FDA-cleared AI-powered software that continuously evaluates the risk of a hospitalized patient's death or transfer to ICU, enabling early intervention and improved outcomes.

AgileMD's eCARTv5 Clinical Deterioration Suite is an FDA-cleared, AI-powered Software as a Medical Device (SaMD) that integrates with EHRs to continuously assess and predict the risk of clinical deterioration (death or ICU transfer) in hospitalized adult patients, guiding care with embedded clinical pathways.

An AI algorithm for screening cardiac amyloidosis using standard 12-lead ECGs.

Anumana's FDA-cleared ECG-AI LEF 12-Lead algorithm uses artificial intelligence to detect low ejection fraction from routine 12-lead ECGs, aiding in the early identification of heart failure risk.

An AI algorithm that analyzes standard 12-lead ECG recordings to detect signs of pulmonary hypertension, aiming for earlier diagnosis and improved patient outcomes.

EchoNext is an FDA-cleared AI tool from Pathway Labs that analyzes standard ECGs to detect hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension.

EchoSolv AS is an FDA-cleared, AI-powered clinical decision support platform by Echo IQ that analyzes echocardiograms to identify patients at risk for severe aortic stenosis with high accuracy and efficiency, integrating into existing workflows.

EFAI CARDIOSUITE CTA ACUTE AORTIC SYNDROME ASSESSMENT SYSTEM is an AI-powered radiological computer-assisted triage and notification software that rapidly detects features suggestive of acute aortic dissection or intramural hematoma from CTA images, alerting PACS/RIS workstations for earlier review.

AI-powered computer-aided triage and notification software for assessing malpositioned endotracheal tubes on chest X-rays, designed to enhance patient safety and improve clinical outcomes through rapid alerts.

The EFAI ChestSuite XR Pleural Effusion Assessment System is an AI-powered radiological computer-assisted triage and notification software that analyzes PA chest X-rays to identify and flag suspected pleural effusion, aiding in workflow prioritization.

The EFAI ChestSuite XR Pneumothorax Assessment System is an FDA-cleared AI-powered radiological computer-assisted triage and notification software. It uses deep learning to analyze adult PA chest X-rays for suspected pneumothorax, sending notifications to PACS/workstations to aid in worklist prioritization and clinical assessment.